Energy-dependent accumulation of calcium antagonists in catecholamine storage vesicles

Biochemical Pharmacology

Volumn 59, Issue 2, 2000, Pages 123-129

  Terland, Ole ^a   Flatmark, Torgeir ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Active uptake; Amlodipine; Calcium antagonist; Chromaffin granules; Mibefradil; Nitrendipine; Vacuolar H+ ATPase; Verapamil

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AMLODIPINE; BAFILOMYCIN A1; CALCIUM ANTAGONIST; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CATECHOLAMINE; MIBEFRADIL; NITRENDIPINE; PROTON PUMP; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHROMAFFIN GRANULE; CONTROLLED STUDY; DRUG ACCUMULATION; IN VITRO STUDY; MEMBRANE POTENTIAL; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM CHANNEL BLOCKERS; CATECHOLAMINES; CATTLE; CHROMAFFIN GRANULES; ENERGY METABOLISM; NITRENDIPINE; PROTON-TRANSLOCATING ATPASES; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 0033990503     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00307-X     Document Type: Article

References (31)

1. +-ATPase and bioenergetics of catecholamine storage vesicles. Eur J Pharmacol. 207:1991;37-41.
2. Grønberg M., Terland O., Husebye E.S., Flatmark T. The effect of prenylamine and organic nitrates on the bioenergetics of bovine catecholamine storage vesicles. Biochem Pharmacol. 40:1990;351-355.
3. +-ATPase in catecholamine storage vesicles . Neuropharmacology. 38:1999;879-882.
4. Arrowsmith J.E., Campbell S.F., Cross P.E., Stubbs J.K., Burges R.A., Gardiner D.G., Blackburn K.J. Long-acting dihydropyridine calcium antagonists. 1.2-Alkoxymethyl derivatives incorporating basic substituents. J Med Chem. 29:1986;1696-1702.
5. Burges R.A., Gardiner D.G., Gwilt M., Higgins A.J., Blackburn K.J., Campbell S.F., Cross P.E., Stubbs J.K. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: Evidence for voltage modulation of vascular dihydropyridine receptors. J Cardiovasc Pharmacol. 9:1987;110-119.
6. Johnson R.G. Accumulation of biological amines into chromaffin granules A model for hormone and neurotransmitter transport . Physiol Rev. 68:1988;232-307.
7. Herling A.W., Ljungström M. Effects of verapamil on gastric acid secretion in vitro and in vivo. Eur J Pharmacol. 156:1988;341-350.
8. Hasegawa J., Fujita T., Hayashi Y., Iwamoto K., Watanabe J. pKa determination of verapamil by liquid-liquid partition. J Pharm Sci. 73:1984;442-445.
9. 2+ channel blocker . Exp Opin Invest Drugs. 6:1997;569-582.
10. Terland O., Flatmark T. Oxidoreductase activities of chromaffin granule ghosts isolated from the bovine adrenal medulla. Biochim Biophys Acta. 597:1980;318-330.
11. Peter D., Jimenez J., Liu Y., Kim J., Edwards R.H. The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J Biol Chem. 269:1994;7231-7237.
12. 2+-dependent ATPase in bovine adrenal chromaffin granules. With special reference to the effect of inhibitors and energy coupling. Eur J Biochem. 164:1987;1-8.
13. Husebye E.S., Flatmark T. Characterization of phospholipase activities in chromaffin granule ghosts isolated from the bovine adrenal medulla. Biochim Biophys Acta. 920:1987;120-130.
14. 2+ channel blockers to the membrane lipid bilayer. Mol Pharmacol. 41:1992;315-321.
15. Herbette L.G., Mason P.E., Gaviraghi G., Tulenko T.N., Mason R.P. The molecular basis for lacidipine's unique pharmacokinetics Optimal hydrophobicity results in membrane interactions that may facilitate the treatment of atherosclerosis . J Cardiovasc Pharmacol. 23:(Suppl 5):1994;S16-S25.
16. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
17. Bowman E.J., Siebers A., Altendorf K. Bafilomycins A class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells . Proc Natl Acad Sci USA. 85:1988;7972-7976.
18. 1. Biochem Biophys Res Commun. 170:1990;873-878.
19. + channel of vacuolar proton pumps. J Biol Chem. 269:1994;17379-17381.
20. Flatmark T., Grønberg M., Husebye E., Berge S.V. Inhibition by N-ethylmaleimide of the MgATP-driven proton pump of the chromaffin granules. FEBS Lett. 149:1982;71-74.
21. Husebye E.S., Flatmark T. The content of long-chain free fatty acids and their effect on energy transduction in chromaffin granule ghosts. J Biol Chem. 259:1984;15272-15276.
22. Kobold G., Langer R., Burger A. Does the carrier of chromaffin granules transport the protonated or the uncharged species of catecholamines? Naunyn Schmiedebergs Arch Pharmacol. 331:1985;209-219.
23. Huyghe B.G., Klinman J.P. Activity of membranous dopamine β-monooxygenase within chromaffin granule ghosts. Interaction with ascorbate. J Biol Chem. 266:1991;11544-11550.
24. Phillips J.H., Apps D.K. Stoichiometry of catecholamine/proton exchange across the chromaffin-granule membrane. Biochem J. 192:1980;273-278.
25. Grossman E., Messerli F.H. Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressure. Am J Cardiol. 80:1997;1453-1458.
26. Kailasam M.T., Parmer R.J., Cervenka J.H., Wu R.A., Ziegler M.G., Kennedy B.P., Adegbile I.A., O'Connor D.T. Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension. Hypertension. 26:1995;143-149.
27. Muiesan G., Agabiti-Rosei E., Castellano M., Alicandri C.L., Corea L., Fariello R., Beschi M., Romanelli G. Antihypertensive and humoral effects of verapamil and nifedipine in essential hypertension. J Cardiovasc Pharmacol. 4:(Suppl 3):1982;S325-S329.
28. Halperin A.K., Icenogle M.V., Kapsner C.O., Chick T.W., Roehnert J., Murata G.H. A comparison of the effects of nifedipine and verapamil on exercise performance in patients with mild to moderate hypertension. Am J Hypertens. 6:1993;1025-1032.
29. Leenen F.H.H., Fourney A. Comparison of the effects of amlodipine and diltiazem on 24-hour blood pressure, plasma catecholamines, and left ventricular mass. Am J Cardiol. 78:1996;203-207.
30. Schmitt R., Kleinbloesem C.H., Belz G.G., Shroeter V., Feifel U., Pozenel H., Kirch W., Halabi A., Woittiez A.J.J., Welker H.A., Brummelen P. Hemodynamic and humoral effects of the novel calcium antagonist Ro 40-5967 in patients with hypertension. Clin Pharmacol Ther. 52:1992;314-323.
31. 2+ channels by amlodipine. Br J Pharmacol. 121:1997;1136-1140.